D-Index & Metrics Best Publications

François Dabis

University of Bordeaux
France

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 98 Citations 32,927 622 World Ranking 5407 National Ranking 144

Overview

What is he best known for?

The fields of study François Dabis is best known for:

Statistics
Ritonavir
Lopinavir

His Confidence interval research incorporates a variety of disciplines, including Hazard ratio and Relative risk. He connects Hazard ratio with Confidence interval in his study. François Dabis's looking at Population as part of his Poisson regression and Rate ratio and Population study. As part of his studies on Poisson regression, he frequently links adjacent subjects like Environmental health. His Environmental health study typically links adjacent topics like Rate ratio. His Cohort study research spans across into fields like Cohort and Prospective cohort study. He conducts interdisciplinary study in the fields of Cohort and Cohort study through his research. Family medicine is integrated with Nursing and Pediatrics in his research. François Dabis merges many fields, such as Nursing and Family medicine, in his writings.

His most cited work include:

Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis (389 citations)
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies (231 citations)
Cardio- and cerebrovascular events in HIV-infected persons (220 citations)

What are the main themes of his work throughout his whole career to date

His research investigates the link between Demography and topics such as Population that cross with problems in Environmental health. Environmental health is closely attributed to Population in his research. His Cohort study studies intersect with other disciplines such as Cohort and Prospective cohort study. François Dabis performs integrative study on Cohort and Cohort study in his works. He incorporates Internal medicine and Gastroenterology in his studies. In his works, François Dabis conducts interdisciplinary research on Gastroenterology and Internal medicine. His studies link Family medicine with Human immunodeficiency virus (HIV). His Family medicine study frequently draws connections to other fields, such as Human immunodeficiency virus (HIV). He combines topics linked to Viral disease with his work on Immunology.

François Dabis most often published in these fields:

Internal medicine (73.91%)
Human immunodeficiency virus (HIV) (66.30%)
Immunology (51.09%)

What were the highlights of his more recent work (between 2011-2020)?

Internal medicine (77.78%)
Human immunodeficiency virus (HIV) (77.78%)
Environmental health (55.56%)

In recent works François Dabis was focusing on the following fields of study:

While the research belongs to areas of Geometry, François Dabis spends his time largely on the problem of Incidence (geometry), intersecting his research to questions surrounding Optics. His Incidence (geometry) research extends to Optics, which is thematically connected. His research combines Receiver operating characteristic and Internal medicine. His Human immunodeficiency virus (HIV) study frequently involves adjacent topics like Virology. Virology and Human immunodeficiency virus (HIV) are frequently intertwined in his study. His Environmental health study frequently draws connections to adjacent fields such as Child bearing. Child bearing connects with themes related to Population in his study. His Population study frequently draws parallels with other fields, such as Rate ratio. His Rate ratio study frequently draws connections to other fields, such as Environmental health.

Between 2011 and 2020, his most popular works were:

Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial (130 citations)
Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration (50 citations)
HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries (30 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips.
The Lancet (2002)

2020 Citations

Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis

Marie-Louise Newell;Hoosen Coovadia;Marjo Cortina-Borja;Nigel Rollins.
The Lancet (2004)

1360 Citations

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

P Braitstein;Mwg Brinkhof;F Dabis;M Schechter.
The Lancet (2006)

1313 Citations

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

Caroline Sabin;Signe Westring Worm;Rainer Weber.
The Lancet (2008)

1097 Citations

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

Jonathan A C Sterne;Margaret May;Dominique Costagliola;Frank de Wolf.
The Lancet (2009)

1014 Citations

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial

François Dabis;Philippe Msellati;Nicolas Meda;Christiane Welffens-Ekra.
The Lancet (1999)

691 Citations

Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis

A Babiker;S Darby;D De Angelis;D Kwart.
The Lancet (2000)

610 Citations

HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.

Charlotte Lewden;Geneviève Chene;Philippe Morlat;Francois Raffi.
Journal of Acquired Immune Deficiency Syndromes (2007)

496 Citations

Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries

Martin W. G. Brinkhof;François Dabis;Landon Myer;David R. Bangsberg.
Bulletin of The World Health Organization (2008)

431 Citations

Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).

Amanda Mocroft;Jens D Lundgren;Jens D Lundgren;Miriam Lewis Sabin;Antonella d'Arminio Monforte.
PLOS Medicine (2013)

385 Citations

If you think any of the details on this page are incorrect, let us know.